Matthew J. Kolek

1.2k total citations
32 papers, 854 citations indexed

About

Matthew J. Kolek is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Matthew J. Kolek has authored 32 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Matthew J. Kolek's work include Cardiac pacing and defibrillation studies (8 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Matthew J. Kolek is often cited by papers focused on Cardiac pacing and defibrillation studies (8 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Matthew J. Kolek collaborates with scholars based in United States, Japan and Australia. Matthew J. Kolek's co-authors include John F. Carlquist, Jeffrey L. Anderson, Joseph B. Muhlestein, Benjamin D. Horne, Christopher R. Ellis, Bryant M. Whiting, Jessica Clarke, Tami L. Bair, Brent C. James and Benjamin D. Horne and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Matthew J. Kolek

30 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew J. Kolek United States 15 356 190 175 150 133 32 854
Adam Oesterle United States 11 409 1.1× 498 2.6× 138 0.8× 27 0.2× 234 1.8× 29 1.2k
Shiwei Yang China 17 201 0.6× 294 1.5× 94 0.5× 38 0.3× 97 0.7× 59 766
Raúl Altman Argentina 17 686 1.9× 305 1.6× 167 1.0× 22 0.1× 86 0.6× 53 1.2k
Pritesh J. Gandhi United States 15 320 0.9× 377 2.0× 109 0.6× 27 0.2× 209 1.6× 31 992
Annika Asplund Sweden 12 93 0.3× 348 1.8× 53 0.3× 45 0.3× 216 1.6× 18 741
Petru Adrian Mircea Romania 19 53 0.1× 183 1.0× 232 1.3× 94 0.6× 216 1.6× 54 1.0k
Seongmin Kim South Korea 17 68 0.2× 202 1.1× 72 0.4× 69 0.5× 212 1.6× 66 841
Beatriz Tavira Spain 18 61 0.2× 163 0.9× 106 0.6× 61 0.4× 234 1.8× 39 786
Simon P.R. Romaine United Kingdom 10 180 0.5× 183 1.0× 47 0.3× 64 0.4× 353 2.7× 14 821
Karen Janosko United States 9 1.1k 3.1× 305 1.6× 102 0.6× 50 0.3× 221 1.7× 14 1.2k

Countries citing papers authored by Matthew J. Kolek

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Kolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Kolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Kolek more than expected).

Fields of papers citing papers by Matthew J. Kolek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Kolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Kolek. The network helps show where Matthew J. Kolek may publish in the future.

Co-authorship network of co-authors of Matthew J. Kolek

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Kolek. A scholar is included among the top collaborators of Matthew J. Kolek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Kolek. Matthew J. Kolek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellis, Christopher R., Arnold J. Greenspon, Paul A. Gould, et al.. (2023). Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients. Circulation Arrhythmia and Electrophysiology. 16(5). e011740–e011740. 8 indexed citations
2.
Kolek, Matthew J., George H. Crossley, & Christopher R. Ellis. (2017). Implantation of a MICRA Leadless Pacemaker Via Right Internal Jugular Vein. JACC. Clinical electrophysiology. 4(3). 420–421. 18 indexed citations
4.
Yoneda, Zachary T., Jay A. Montgomery, Diane M. Crawford, et al.. (2017). Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotype. PLoS ONE. 12(9). e0184354–e0184354. 9 indexed citations
5.
Kolek, Matthew J., et al.. (2016). New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic. Value in Health. 19(7). A719–A719. 2 indexed citations
6.
Kolek, Matthew J. & Christopher R. Ellis. (2014). New Approaches to Decrease Cardiac Implantable Electronic Device Infections. Cardiac Electrophysiology Clinics. 6(2). 279–284. 2 indexed citations
7.
Kolek, Matthew J., Todd L. Edwards, Raafia Muhammad, et al.. (2014). A Genome-Wide Association Study to Identify Genomic Modulators of Rate Control Therapy in Patients With Atrial Fibrillation. The American Journal of Cardiology. 114(4). 593–600. 9 indexed citations
8.
Balouch, Muhammad, Matthew J. Kolek, & Dawood Darbar. (2014). Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways. Global Cardiology Science and Practice. 2014(1). 5–5. 18 indexed citations
9.
Kolek, Matthew J., Babar Parvez, Raafia Muhammad, et al.. (2013). A Common Variant on Chromosome 4q25 is Associated With Prolonged PR Interval in Subjects With and Without Atrial Fibrillation. The American Journal of Cardiology. 113(2). 309–313. 15 indexed citations
10.
Anderson, Jeffrey L., Benjamin D. Horne, Matthew J. Kolek, et al.. (2008). Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. American Heart Journal. 156(6). 1155–1162.e2. 54 indexed citations
11.
Horne, Benjamin D., Nicola J. Camp, Jeffrey L. Anderson, et al.. (2007). Multiple Less Common Genetic Variants Explain the Association of the Cholesteryl Ester Transfer Protein Gene With Coronary Artery Disease. Journal of the American College of Cardiology. 49(20). 2053–2060. 14 indexed citations
12.
Horne, Benjamin D., Nicola J. Camp, John F. Carlquist, et al.. (2007). Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. American Heart Journal. 154(4). 751–758. 55 indexed citations
13.
Rondina, Matthew T., Jason M. Lappé, John F. Carlquist, et al.. (2007). Soluble CD40 Ligand as a Predictor of Coronary Artery Disease and Long-Term Clinical Outcomes in Stable Patients Undergoing Coronary Angiography. Cardiology. 109(3). 196–201. 22 indexed citations
14.
May, Heidi T., Benjamin D. Horne, Jeffrey L. Anderson, et al.. (2006). Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death. American Heart Journal. 152(5). 997–1003. 42 indexed citations
15.
Horne, Benjamin D., John F. Carlquist, Lisa Cannon‐Albright, et al.. (2006). High‐Resolution Characterization of Linkage Disequilibrium Structure and Selection of Tagging Single Nucleotide Polymorphisms: Application to the Cholesteryl Ester Transfer Protein Gene. Annals of Human Genetics. 70(4). 524–534. 12 indexed citations
16.
Carlquist, John F., Benjamin D. Horne, Joseph B. Muhlestein, et al.. (2006). Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study. Journal of Thrombosis and Thrombolysis. 22(3). 191–197. 172 indexed citations
17.
Kolek, Matthew J., John F. Carlquist, Surai Thaneemit-Chen, et al.. (2005). The Role of a Common Adenosine Monophosphate Deaminase (AMPD)-1 Polymorphism in Outcomes of Ischemic and Nonischemic Heart Failure. Journal of Cardiac Failure. 11(9). 677–683. 13 indexed citations
18.
Clarke, Jessica, Jeffrey L. Anderson, John F. Carlquist, et al.. (2004). Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessment. The American Journal of Cardiology. 95(1). 155–158. 40 indexed citations
19.
Kolek, Matthew J., John F. Carlquist, Joseph B. Muhlestein, et al.. (2004). Toll–like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. American Heart Journal. 148(6). 1034–1040. 110 indexed citations
20.
Clarke, Jessica, Jeffrey L. Anderson, John F. Carlquist, et al.. (2004). 1117-86 Do differing C-reactive protein assay methods impact cardiovascular risk assessment?. Journal of the American College of Cardiology. 43(5). A288–A288. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026